Baroda BNP Paribas Health and Wellness Fund Review – Baroda BNP Paribas Health and Wellness Fund Review Direct NFO Open on 09 June 2025 and Close on 23 June 2025. Baroda BNP Paribas Health and Wellness Fund Direct NFO Allotment Date is 27 June 2025, and the NFO Type is Open-Ended. NFO Riskometer is Very High Risk, and the Minimum Investment Amount is ₹1,000. The Minimum SIP Investment Amount is ₹500.
Type of the Scheme
An open ended equity scheme investing in Pharma and Healthcare sector.
Scheme Benchmark: BSE Healthcare Total Return Index.
Baroda BNP Paribas Health and Wellness Fund Scheme Benchmark
| Company | Weightage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES | 14.21% |
| DIVIS LABORATORIES LTD. | 6.61% |
| Max Healthcare Institute Limit | 6.52% |
| CIPLA LTD. | 6.5% |
| DR.REDDYS LABORATORIES LTD. | 5.98% |
| APOLLO HOSPITALS ENTERPRISE LT | 5.43% |
| LUPIN LTD. | 3.72% |
| FORTIS HEALTHCARE LTD. | 2.89% |
| TORRENT PHARMACEUTICALS LTD. | 2.61% |
| AUROBINDO PHARMA LTD. | 2.51% |
Baroda BNP Paribas Health and Wellness Fund Important Date
| Scheme Offer | Baroda Mutual Fund |
|---|---|
| Offer Price | Rs. 10/- per Unit |
| Type of Scheme | An open-ended |
| Open Date | 09 June 2025 |
| Close Date | 23 June 2025 |
| Allotment Date | 27 June 2025 |
| Category | Sectoral/Thematic Fund |
| Min Inv ₹ | ₹1,000 |
| Lock in Period | N/A |
| Risk | Very High |
| Scheme Benchmark | BSE Healthcare Total Return Index |
Investment Objective of the Scheme?
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
Baroda BNP Paribas Health and Wellness Fund Other Details
| Exit Load | 1% |
|---|---|
| Exit Load Details | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year. |
| Entry Load | N/A |
| Stamp Duty | 0.005% |
| Min. Investment | Rs. 1,000 |
| Min. SIP | Rs. 500 |
Baroda BNP Paribas Health and Wellness Fund Asset Allocation
| Instruments | Allocation Min | Allocation Max |
|---|---|---|
| Equity and equity related^ instruments of companies in the Pharma & Healthcare and allied sectors | 80% | 100% |
| Equity and equity related instruments of companies other than above | 0% | 20% |
| Debt & Money Market instruments | 0% | 20% |
| Units of Mutual Funds | 0% | 10% |
| Units issued by REITs & InvITs | 0% | 10% |
Manager Manage the Scheme?
Fund Manger : Mr. Sanjay Chawla
Qualification : MMS-BITS, Pilani
Experience : Mr. Chawla has over 33 years of experience in fund management, equity research and Management Consultancy. He was
designated as Chief Investment Officer with Baroda Asset Management India Limited.
Pharma and Healthcare Sector companies include:
- Pharmaceutical & Biotechnology
- Healthcare Services / Healthcare Service Provider
- Healthcare Research, Analytics & Technology
- Hospitals & Diagnostics
- Healthcare Research and/or Manufacturing Services related to Healthcare sector
- Medical Equipment & Supplies
- Pharmacy Retail
- Life Insurance & Medical Insurance Companies and those companies which provide services to the sector.
- And any other business or service directly or indirectly forming part of the Pharma, Healthcare and allied sectors forming part of the Benchmark Index.
Baroda BNP Paribas Health and Wellness Fund Sector Representation
| Sector | Weightage |
|---|---|
| Healthcare | 100% |
Baroda BNP Paribas Health and Wellness Fund Index Return
| Index Return | QTD | YTD | 1 Year | 5 Years | 10 Years |
|---|---|---|---|---|---|
| Price Return | 11.50 | -5.90 | 22.11 | 22.18 | 9.69 |
| Total Return | 11.53 | -5.72 | 22.78 | 22.93 | 10.39 |
Where Will the Scheme Invest?
- Equity and equity related securities are such instruments like Convertible bonds and debentures, Preference shares and warrants carrying the right to obtain equity shares and derivative instruments.
- Foreign securities (including ADRs/GDRs) /Overseas ETFs / Units of Global Mutual Funds in accordance with SEBI Guidelines.
- Units of Real Estate Investment Trusts (REITs) and Infrastructure Investment Trusts (InVITs)
- Money market instruments permitted by SEBI/RBI
- Open ended Mutual Fund Schemes registered with SEBI.
- Commercial Paper (CP), Certificate of Deposits (CD), Treasury Bills, Bills Rediscounting, Tri-party Repo on government securities or T-bills / Reverse Repo.
- Corporate Bonds include all debt instruments issued by entities such as Banks, Public Sector Undertakings, Government Agencies and other Statutory Bodies, Municipal Corporations, body corporate, companies, trusts/ Special Purpose Vehicles etc and would exclude investments in
Government Securities issued by Central and State Government. - Deposits with banks and other bodies corporate as may be permitted by SEBI from time to time.
- Any other debt and money market instruments that may be available from time to time.
- Funds from time to time. Investments in Tri-Party Repo on Government Securities or T-bills would be as per the RBI circular dated July 24, 2018.
- Mutual fund scheme shall not invest in unlisted debt instruments including commercial papers (CPs), other than (a) government securities, (b) other money market instruments.
Also Read: Tata Nifty Midcap 150 Index Fund
Baroda BNP Paribas Health and Wellness Fund Registrar
KFIN TECHNOLOGIES LIMITED
Tel No.: +91 40 6716 2222
Website: Www.Kfintech.Com
Email: Hoacfoods.Ipo@Kfintech.Com
Investor Grievance Email:Einward.Ris@Kfintech.Com
Contact Person: Mr. M Murali Krishna
Baroda BNP Paribas Health and Wellness Fund Form Download
People also ask F&Q
Question 1: Is Baroda BNP Paribas Health and Wellness Fund good or bad?
Answer 1: Yes, Baroda BNP Paribas Health and Wellness Fund is a good choice for investors & Retailer Also.
Question 2: What NAV will I get, if I invest in NFO period of Baroda BNP Paribas Health and Wellness Fund?
Answer 1: A NAV of approx ₹10.00/-
1 thought on “Baroda BNP Paribas Health and Wellness Fund Review – Direct Plan”